Development of novel risperidone implants using blends of polycaprolactones and in vitro in vivo correlation studies
The objective of this study was to develop a novel implant containing risperidone intended for long-term treatment in Schizophrenia utilizing in vitro in vivo correlation (IVIVC) studies. Different implants (F1-F8) containing an antipsychotic drug, risperidone, were prepared using a hot melt extrusi...
Saved in:
Main Authors: | Aerrolla Navitha (Author), Satheesh Jogala (Author), Chinnala Krishnamohan (Author), Jithan Aukunuru (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of a novel 3-month drug releasing risperidone microspheres
by: Bhanusree Yerragunta, et al.
Published: (2015) -
Development of subcutaneous sustained release nanoparticles encapsulating low molecular weight heparin
by: Satheesh Jogala, et al.
Published: (2015) -
Polycaprolactone - Vitamin E TPGS micelles for delivery of paclitaxel: In vitro and in vivo evaluation
by: Ziyad Binkhathlan, et al.
Published: (2024) -
Physiologically-Based Pharmacokinetic Modeling and In Vitro-In Vivo Correlation of TV-46000 (Risperidone LAI): Prediction from Dog to Human
by: David Bibi, et al.
Published: (2024) -
Formulation of risperidone loaded proniosomes for effective transdermal delivery: An in-vitro and in-vivo study
by: Sharda Sambhakar, et al.
Published: (2017)